Paper28483
Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
Siber GR and 4 others. N Engl J Med, 1978. Cited by 221 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. Papers, record 28483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28483
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Bacterial Vaccines | Major topic |
| Hodgkin Disease | Major topic |
| Streptococcus pneumoniae | Major topic |
| Adolescent | |
| Adult | |
| Antibody Formation | |
| Child | |
| Humans | |
| Immunization | |
| Middle Aged | |
| Polysaccharides, Bacterial | |
| Splenectomy | |
| Time Factors |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,899,075 | Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers. | Sci Rep | 2023 | https://conductscience.org/library/papers/36899075 | PubMed |
| 35,081,732 | Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study. | Future Oncol | 2022 | https://conductscience.org/library/papers/35081732 | PubMed |
| 34,047,765 | Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34047765 | PubMed |
| 28,828,339 | The Immune Response of Vaccination Against Hepatitis B virus in Iranian Patients Undergoing Chemotherapy. | Adv Biomed Res | 2017 | https://conductscience.org/library/papers/28828339 | PubMed |
| 27,648,207 | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety. | Mediterr J Hematol Infect Dis | 2016 | https://conductscience.org/library/papers/27648207 | PubMed |
| 11,100,283 | Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma. | Bone Marrow Transplant | 2000 | https://conductscience.org/library/papers/11100283 | PubMed |
| 9,384,280 | Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines. | Clin Diagn Lab Immunol | 1997 | https://conductscience.org/library/papers/9384280 | PubMed |
| 8,846,624 | Optimal delivery of vaccines: clinical pharmacokinetic considerations. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8846624 | PubMed |
| 8,601,117 | Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. | BMJ | 1996 | https://conductscience.org/library/papers/8601117 | PubMed |
| 8,432,585 | Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. | Infect Immun | 1993 | https://conductscience.org/library/papers/8432585 | PubMed |
| 7,883,209 | Hyposplenism in gastrointestinal disease. | Gut | 1995 | https://conductscience.org/library/papers/7883209 | PubMed |
| 7,399,682 | Graphical method for evaluating antibody response to vaccines. | Infect Immun | 1980 | https://conductscience.org/library/papers/7399682 | PubMed |
| 7,334,071 | Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/7334071 | PubMed |
| 7,305,495 | The risk of sepsis in the asplenic adult. | Ann Surg | 1981 | https://conductscience.org/library/papers/7305495 | PubMed |
| 7,216,447 | Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. | Infect Immun | 1981 | https://conductscience.org/library/papers/7216447 | PubMed |
| 7,068,216 | Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers. | Infect Immun | 1982 | https://conductscience.org/library/papers/7068216 | PubMed |
| 7,015,698 | The overwhelming postsplenectomy sepsis problem. | World J Surg | 1980 | https://conductscience.org/library/papers/7015698 | PubMed |
| 6,996,624 | Response of renal allograft recipients to pneumococcal vaccine. | Ann Surg | 1980 | https://conductscience.org/library/papers/6996624 | PubMed |
| 6,616,391 | Overwhelming pneumococcal infection in a hyposplenic adult. | Can Med Assoc J | 1983 | https://conductscience.org/library/papers/6616391 | PubMed |
| 6,601,061 | Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. | Infect Immun | 1983 | https://conductscience.org/library/papers/6601061 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28483
GET https://conductscience.org/api/papers/v1/28483/cited_by?page=2